Dr. Peter Attia

I see. Okay. So nowadays we're doing that in parallel. Oh, for sure on parallel.

I see. Okay. So nowadays we're doing that in parallel. Oh, for sure on parallel.

So how long, just to again, go back to helping people think through the arc of time, from the moment you guys hit a go decision on, we want to do this, we want to pursue this path, how long until you file the IND?

So how long, just to again, go back to helping people think through the arc of time, from the moment you guys hit a go decision on, we want to do this, we want to pursue this path, how long until you file the IND?

Maybe tell folks what the IND is so they understand why that's an important milestone.

Maybe tell folks what the IND is so they understand why that's an important milestone.

So we're going to do the Peter Sue drug. It's going to be amazing. We're going to set the lab up right over there. But the moment we want to run a clinical trial. And ship it. And get it out of the state.

So we're going to do the Peter Sue drug. It's going to be amazing. We're going to set the lab up right over there. But the moment we want to run a clinical trial. And ship it. And get it out of the state.

And there's an art to knowing where to start the dose because it's an escalating dose trial. That's right. But you're extrapolating from what you learned about toxicity in a totally different organism that never translates one-to-one to the organism of choice.

And there's an art to knowing where to start the dose because it's an escalating dose trial. That's right. But you're extrapolating from what you learned about toxicity in a totally different organism that never translates one-to-one to the organism of choice.

And typical cost given the relatively low numbers of patients?

And typical cost given the relatively low numbers of patients?

Tens of millions, yeah.

Tens of millions, yeah.

What's the right outcome? What's the right patient?

What's the right outcome? What's the right patient?

So where were you guys with anti-VEGF in phase two? You're at breast cancer and did you do colon?

So where were you guys with anti-VEGF in phase two? You're at breast cancer and did you do colon?

Five of you and the usual suspects.

Five of you and the usual suspects.